[1] BHATT D L, LOPES R D, HARRINGTON R A. Diagnosis and treatment of acute coronary syndromes: a review[J]. JAMA, 2022, 327(7): 662-675. [2] YANG M, CHEN J, ZHAO J, et al. Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress[J]. PLoS One, 2014, 9(9): e108024. [3] WU H, JIA S, LIAO B, et al. Establishment of a mortality risk nomogram for predicting in-hospital mortality of sepsis: cohort study from a Chinese single center[J]. Front Med: Lausanne, 2024, 11: 1360197. [4] CARLISI M, PRESTI R L, MANCUSO S, et al. Calculated whole blood viscosity and albumin/fibrinogen ratio in patients with a new diagnosis of multiple myeloma: relationships with some prognostic predictors[J]. Biomedicines, 2023, 11(3): 964. [5] MENG H, GUO L, PAN Y, et al. Machine learning based clinical prediction model for 1-year mortality in sepsis patients with atrial fibrillation[J]. Heliyon, 2024, 10(21): e38730. [6] LIN S, MAO X, HE W, et al. Association between red blood cell distribution width-to-platelet ratio and post-discharge readmission rate in patients with heart failure: a retrospective cohort study[J]. Heliyon, 2024, 10(4): e26549. [7] LAKHAL-LITTLETON S, ROBBINS P A. The interplay between iron and oxygen homeostasis with a particular focus on the heart[J]. J Appl Physiol: 1985, 2017, 123(4): 967-973. [8] BAO D, LUO G, KAN F, et al. Prognostic value of red cell distribution width in patients undergoing percutaneous coronary intervention: a meta-analysis[J]. BMJ Open, 2020, 10(9): e033378. [9] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志,2019,47(10) : 766-783. [10] DE FILIPPO O, D’ASCENZO F, RAPOSEIRAS-ROUBIN S, et al. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects[J]. Eur Heart J Cardiovasc Pharmacother, 2020, 6(1): 31-42. [11] FORD J. Red blood cell morphology[J]. Int J Lab Hematol, 2013, 35(3):351-357. [12] YČAS J W, HORROW J C, HORNE B D. Persistent increase in red cell size distribution width after acute diseases: a biomarker of hypoxemia?[J]. Clin Chim Acta, 2015, 448: 107-117. [13] BARUA S, CIANNELLA S, TIJANI L, et al. Iron in blood cells: function, relation to disease, and potential for magnetic separation[J]. Biotechnol Bioeng, 2023, 120(7): 1707-1724. [14] GANZ T. Hepcidin and its role in regulating systemic iron metabolism[J]. Hematology Am Soc Hematol Educ Program, 2006: 29-35, 507. [15] VERGA FALZACAPPA M V, VUJIC SPASIC M, KESSLER R, et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation[J]. Blood, 2007, 109(1): 353-358. [16] TONELLI M, SACKS F, ARNOLD M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease[J]. Circulation, 2008, 117(2): 163-168. [17] DABBAH S, HAMMERMAN H, MARKIEWICZ W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction[J]. Am J Cardiol, 2010, 105(3): 312-317. [18] SKJELBAKKEN T, LAPPEGÅRD J, ELLINGSEN T S, et al. Red cell distribution width is associated with incident myocardial infarction in a general population: the Tromsø Study[J]. J Am Heart Assoc, 2014, 3(4): e001109. [19] UYAREL H, ERGELEN M, CICEK G, et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction[J]. Coron Artery Dis, 2011, 22(3): 138-144. [20] LI Y, LI M, TENG Y, et al. The association between red cell distribution width, erythropoietin levels, and coronary artery disease[J]. Coron Artery Dis, 2018, 29(1): 74-80. [21] GHAFFARI S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis[J]. Antioxid Redox Signal, 2008, 10(11): 1923-1940. [22] LI S, ZHANG W, LIANG X. Red blood cell distribution width and mortality risk in critically ill cardiovascular patients[J]. Heliyon, 2023, 9(11): e22225. |